Bellevue Life Sciences Acquisition Corp. – NASDAQ:BLAC

Bellevue Life Sciences Acquisition Corp. stock price today

$2.807
-8.72
-75.66%
Financial Health
0
1
2
3
4
5
6
7
8
9

Bellevue Life Sciences Acquisition Corp. stock price monthly change

+6.76%
month

Bellevue Life Sciences Acquisition Corp. stock price quarterly change

+6.76%
quarter

Bellevue Life Sciences Acquisition Corp. stock price yearly change

+10.12%
year

Bellevue Life Sciences Acquisition Corp. key metrics

Market Cap
45.54M
Enterprise value
N/A
P/E
N/A
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
N/A
Price/Book
N/A
PEG ratio
N/A
EPS
0.01
Revenue
N/A
EBITDA
-2.00M
Income
233.04K
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Bellevue Life Sciences Acquisition Corp. stock price history

Bellevue Life Sciences Acquisition Corp. stock forecast

Bellevue Life Sciences Acquisition Corp. financial statements

Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC): Profit margin
Jun 2023 0 301.46K
Sep 2023 0 78.18K
Dec 2023 0 -86.17K
Mar 2024 0 -60.43K
Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC): Debt to assets
Jun 2023 71494506 2.61M 3.65%
Sep 2023 72136443 3.17M 4.4%
Dec 2023 36627733 4.10M 11.22%
Mar 2024 37274110 4.81M 12.92%
Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC): Cash Flow
Jun 2023 -347.62K 0 0
Sep 2023 -143.22K 0 200K
Dec 2023 -279.49K 36.37M -36.14M
Mar 2024 -41.78K -120K 150K

Bellevue Life Sciences Acquisition Corp. other data

Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC): Insider trades (number of shares)
Period Buy Sel
Feb 2023 860000 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
BELLEVUE GLOBAL LIFE SCIENCE INVESTORS LLC 10 percent owner
Private Placement Warrants 430,000 $11.5 $4,945,000
Purchase
HWANG KUK HYOUN director, 10 percent owner, off..
Private Placement Warrants 430,000 $11.5 $4,945,000
  • What's the price of Bellevue Life Sciences Acquisition Corp. stock today?

    One share of Bellevue Life Sciences Acquisition Corp. stock can currently be purchased for approximately $2.81.

  • When is Bellevue Life Sciences Acquisition Corp.'s next earnings date?

    Unfortunately, Bellevue Life Sciences Acquisition Corp.'s (BLAC) next earnings date is currently unknown.

  • Does Bellevue Life Sciences Acquisition Corp. pay dividends?

    No, Bellevue Life Sciences Acquisition Corp. does not pay dividends.

  • How much money does Bellevue Life Sciences Acquisition Corp. make?

    Bellevue Life Sciences Acquisition Corp. has a market capitalization of 45.54M.

  • What is Bellevue Life Sciences Acquisition Corp.'s stock symbol?

    Bellevue Life Sciences Acquisition Corp. is traded on the NASDAQ under the ticker symbol "BLAC".

  • What is Bellevue Life Sciences Acquisition Corp.'s primary industry?

    Company operates in the Financial Services sector and Shell Companies industry.

  • How do i buy shares of Bellevue Life Sciences Acquisition Corp.?

    Shares of Bellevue Life Sciences Acquisition Corp. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • When Bellevue Life Sciences Acquisition Corp. went public?

    Bellevue Life Sciences Acquisition Corp. is publicly traded company for more then 2 years since IPO on 21 Mar 2023.

  • Where are Bellevue Life Sciences Acquisition Corp.'s headquarters?

    Bellevue Life Sciences Acquisition Corp. is headquartered at 10900 NE 4th Street, Bellevue, WA.

  • How can i contact Bellevue Life Sciences Acquisition Corp.?

    Bellevue Life Sciences Acquisition Corp.'s mailing address is 10900 NE 4th Street, Bellevue, WA and company can be reached via phone at 425 635 7700.

Bellevue Life Sciences Acquisition Corp. company profile:

Bellevue Life Sciences Acquisition Corp.

Exchange:

NASDAQ

Full time employees:

0

Industry:

Shell Companies

Sector:

Financial Services

Bellevue Life Sciences Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company intends to acquire companies in the healthcare industry. Bellevue Life Sciences Acquisition Corp. was founded in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.

10900 NE 4th Street
Bellevue, WA 98004

CIK: 0001840425
ISIN: US0791741087
CUSIP: 079174108